Lab equipment maker Waters Corp on Monday said it will buy a bioscience and diagnostics unit spun off from medtech provider ...

A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete ...

Becton, Dickinson and Company is an attractive firm that just made a good deal. Click here to find out why BDX stock is a Buy ...

Becton, Dickinson and Company (NYSE:BDX) is one of the stocks on Jim Cramer’s radar. Cramer mentioned the stock in light of ...

The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of ...

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the ...

Becton, Dickinson's divestment enhances focus, reduces leverage, funds buybacks, and unlocks value. Read more about the M&A ...

Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...

Medical analysis equipment maker Waters is combining with a unit of Becton Dickinson in a complex spin-merge. At a discount ...

Waters, a maker of lab equipment and software, will issue around 39% of its shares to Becton shareholders and assume $4 billion of debt to acquire the biosciences and diagnostic solutions business.

Waters plans to combine with the Biosciences & Diagnostic Solutions business of BD (Becton, Dickinson & Co.), the companies said, in a $17.5 billion deal that would be the year’s largest within life ...

Three months earlier than an expected update on a deal, Becton, Dickinson and Co. reported its biosciences and diagnostic ...